nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP1A2—Carmustine—malignant glioma	0.269	0.57	CbGbCtD
Dapagliflozin—CYP3A4—Temozolomide—malignant glioma	0.203	0.431	CbGbCtD
Dapagliflozin—SLC5A11—telencephalon—malignant glioma	0.0126	0.139	CbGeAlD
Dapagliflozin—SLC5A11—medulla oblongata—malignant glioma	0.00986	0.109	CbGeAlD
Dapagliflozin—SLC5A11—midbrain—malignant glioma	0.00901	0.0999	CbGeAlD
Dapagliflozin—SLC5A11—spinal cord—malignant glioma	0.00879	0.0974	CbGeAlD
Dapagliflozin—SLC5A4—central nervous system—malignant glioma	0.00786	0.087	CbGeAlD
Dapagliflozin—SLC5A11—central nervous system—malignant glioma	0.00713	0.079	CbGeAlD
Dapagliflozin—SLC5A11—cerebellum—malignant glioma	0.00697	0.0773	CbGeAlD
Dapagliflozin—SLC5A4—brain—malignant glioma	0.00624	0.0691	CbGeAlD
Dapagliflozin—SLC5A11—brain—malignant glioma	0.00566	0.0628	CbGeAlD
Dapagliflozin—Lung disorder—Temozolomide—malignant glioma	0.00213	0.053	CcSEcCtD
Dapagliflozin—Extravasation—Carmustine—malignant glioma	0.00179	0.0445	CcSEcCtD
Dapagliflozin—CYP2A6—cerebellum—malignant glioma	0.0016	0.0178	CbGeAlD
Dapagliflozin—ABCB1—blood vessel—malignant glioma	0.0016	0.0177	CbGeAlD
Dapagliflozin—Vaginal infection—Temozolomide—malignant glioma	0.00142	0.0354	CcSEcCtD
Dapagliflozin—Neoplasm—Carmustine—malignant glioma	0.00141	0.0351	CcSEcCtD
Dapagliflozin—Neoplasm—Temozolomide—malignant glioma	0.00136	0.0339	CcSEcCtD
Dapagliflozin—Phlebitis—Carmustine—malignant glioma	0.00131	0.0327	CcSEcCtD
Dapagliflozin—CYP2A6—brain—malignant glioma	0.0013	0.0144	CbGeAlD
Dapagliflozin—Diabetes mellitus—Carmustine—malignant glioma	0.0013	0.0324	CcSEcCtD
Dapagliflozin—CYP2D6—brainstem—malignant glioma	0.00122	0.0135	CbGeAlD
Dapagliflozin—Thirst—Temozolomide—malignant glioma	0.00115	0.0286	CcSEcCtD
Dapagliflozin—Hyponatraemia—Carmustine—malignant glioma	0.00114	0.0283	CcSEcCtD
Dapagliflozin—CYP2D6—telencephalon—malignant glioma	0.00108	0.012	CbGeAlD
Dapagliflozin—Dehydration—Temozolomide—malignant glioma	0.00102	0.0253	CcSEcCtD
Dapagliflozin—ABCB1—embryo—malignant glioma	0.000955	0.0106	CbGeAlD
Dapagliflozin—Dysuria—Temozolomide—malignant glioma	0.000883	0.022	CcSEcCtD
Dapagliflozin—Pollakiuria—Temozolomide—malignant glioma	0.000872	0.0217	CcSEcCtD
Dapagliflozin—Renal failure—Carmustine—malignant glioma	0.000856	0.0213	CcSEcCtD
Dapagliflozin—CYP1A1—central nervous system—malignant glioma	0.00085	0.00942	CbGeAlD
Dapagliflozin—Urinary tract infection—Carmustine—malignant glioma	0.000847	0.0211	CcSEcCtD
Dapagliflozin—ABCB1—retina—malignant glioma	0.000844	0.00936	CbGeAlD
Dapagliflozin—Infestation—Temozolomide—malignant glioma	0.000842	0.021	CcSEcCtD
Dapagliflozin—Infestation NOS—Temozolomide—malignant glioma	0.000842	0.021	CcSEcCtD
Dapagliflozin—Urinary tract infection—Temozolomide—malignant glioma	0.000818	0.0204	CcSEcCtD
Dapagliflozin—ABCB1—telencephalon—malignant glioma	0.000777	0.00861	CbGeAlD
Dapagliflozin—Connective tissue disorder—Carmustine—malignant glioma	0.000769	0.0191	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Temozolomide—malignant glioma	0.000746	0.0186	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Temozolomide—malignant glioma	0.000743	0.0185	CcSEcCtD
Dapagliflozin—Urethral disorder—Temozolomide—malignant glioma	0.000741	0.0185	CcSEcCtD
Dapagliflozin—Malnutrition—Carmustine—malignant glioma	0.000681	0.017	CcSEcCtD
Dapagliflozin—CYP1A1—brain—malignant glioma	0.000675	0.00748	CbGeAlD
Dapagliflozin—Back pain—Carmustine—malignant glioma	0.000659	0.0164	CcSEcCtD
Dapagliflozin—Malnutrition—Temozolomide—malignant glioma	0.000658	0.0164	CcSEcCtD
Dapagliflozin—Back pain—Temozolomide—malignant glioma	0.000636	0.0158	CcSEcCtD
Dapagliflozin—CYP3A4—central nervous system—malignant glioma	0.000624	0.00691	CbGeAlD
Dapagliflozin—CYP2D6—central nervous system—malignant glioma	0.000614	0.0068	CbGeAlD
Dapagliflozin—ABCB1—medulla oblongata—malignant glioma	0.00061	0.00676	CbGeAlD
Dapagliflozin—Angioedema—Temozolomide—malignant glioma	0.000601	0.015	CcSEcCtD
Dapagliflozin—CYP2D6—cerebellum—malignant glioma	0.0006	0.00665	CbGeAlD
Dapagliflozin—Hypertension—Carmustine—malignant glioma	0.000588	0.0146	CcSEcCtD
Dapagliflozin—Hypertension—Temozolomide—malignant glioma	0.000568	0.0141	CcSEcCtD
Dapagliflozin—ABCB1—midbrain—malignant glioma	0.000558	0.00618	CbGeAlD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000556	0.0139	CcSEcCtD
Dapagliflozin—Oedema—Carmustine—malignant glioma	0.000556	0.0138	CcSEcCtD
Dapagliflozin—Discomfort—Temozolomide—malignant glioma	0.000553	0.0138	CcSEcCtD
Dapagliflozin—Infection—Carmustine—malignant glioma	0.000552	0.0137	CcSEcCtD
Dapagliflozin—ABCB1—spinal cord—malignant glioma	0.000544	0.00603	CbGeAlD
Dapagliflozin—Anaphylactic shock—Temozolomide—malignant glioma	0.000537	0.0134	CcSEcCtD
Dapagliflozin—Oedema—Temozolomide—malignant glioma	0.000537	0.0134	CcSEcCtD
Dapagliflozin—Infection—Temozolomide—malignant glioma	0.000533	0.0133	CcSEcCtD
Dapagliflozin—Skin disorder—Temozolomide—malignant glioma	0.000522	0.013	CcSEcCtD
Dapagliflozin—Hypotension—Carmustine—malignant glioma	0.000519	0.0129	CcSEcCtD
Dapagliflozin—Hyperhidrosis—Temozolomide—malignant glioma	0.000519	0.0129	CcSEcCtD
Dapagliflozin—CYP2D6—brain—malignant glioma	0.000487	0.0054	CbGeAlD
Dapagliflozin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00048	0.0119	CcSEcCtD
Dapagliflozin—Constipation—Carmustine—malignant glioma	0.000475	0.0118	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000464	0.0115	CcSEcCtD
Dapagliflozin—Constipation—Temozolomide—malignant glioma	0.000459	0.0114	CcSEcCtD
Dapagliflozin—ABCB1—central nervous system—malignant glioma	0.000442	0.00489	CbGeAlD
Dapagliflozin—Body temperature increased—Carmustine—malignant glioma	0.000439	0.0109	CcSEcCtD
Dapagliflozin—ABCB1—cerebellum—malignant glioma	0.000432	0.00478	CbGeAlD
Dapagliflozin—Urticaria—Temozolomide—malignant glioma	0.000427	0.0106	CcSEcCtD
Dapagliflozin—Body temperature increased—Temozolomide—malignant glioma	0.000424	0.0106	CcSEcCtD
Dapagliflozin—Hypersensitivity—Carmustine—malignant glioma	0.000409	0.0102	CcSEcCtD
Dapagliflozin—Hypersensitivity—Temozolomide—malignant glioma	0.000396	0.00985	CcSEcCtD
Dapagliflozin—Dizziness—Carmustine—malignant glioma	0.000367	0.00915	CcSEcCtD
Dapagliflozin—Dizziness—Temozolomide—malignant glioma	0.000355	0.00884	CcSEcCtD
Dapagliflozin—ABCB1—brain—malignant glioma	0.000351	0.00388	CbGeAlD
Dapagliflozin—Rash—Carmustine—malignant glioma	0.00035	0.00873	CcSEcCtD
Dapagliflozin—Dermatitis—Carmustine—malignant glioma	0.00035	0.00872	CcSEcCtD
Dapagliflozin—Headache—Carmustine—malignant glioma	0.000348	0.00867	CcSEcCtD
Dapagliflozin—Rash—Temozolomide—malignant glioma	0.000339	0.00843	CcSEcCtD
Dapagliflozin—Dermatitis—Temozolomide—malignant glioma	0.000338	0.00842	CcSEcCtD
Dapagliflozin—Headache—Temozolomide—malignant glioma	0.000336	0.00838	CcSEcCtD
Dapagliflozin—Nausea—Carmustine—malignant glioma	0.00033	0.00822	CcSEcCtD
Dapagliflozin—Nausea—Temozolomide—malignant glioma	0.000319	0.00794	CcSEcCtD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—malignant glioma	7.09e-05	0.000178	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP2C18—malignant glioma	6.97e-05	0.000175	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS1—malignant glioma	6.85e-05	0.000172	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.83e-05	0.000171	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	6.82e-05	0.000171	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PIK3CA—malignant glioma	6.75e-05	0.00017	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PIK3CA—malignant glioma	6.75e-05	0.00017	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	6.72e-05	0.000169	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—ASMT—malignant glioma	6.71e-05	0.000169	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.71e-05	0.000169	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	6.69e-05	0.000168	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	6.62e-05	0.000166	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	6.59e-05	0.000166	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	6.48e-05	0.000163	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—BCHE—malignant glioma	6.37e-05	0.00016	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—IDH2—malignant glioma	6.37e-05	0.00016	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—ASMT—malignant glioma	6.33e-05	0.000159	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—BCAN—malignant glioma	6.31e-05	0.000159	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—COX8A—malignant glioma	6.3e-05	0.000158	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—SLC5A5—malignant glioma	6.29e-05	0.000158	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—ASMT—malignant glioma	6.27e-05	0.000157	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GSTP1—malignant glioma	6.24e-05	0.000157	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTEN—malignant glioma	6.19e-05	0.000155	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.16e-05	0.000155	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.13e-05	0.000154	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—AKT1—malignant glioma	6.09e-05	0.000153	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CAT—malignant glioma	6.07e-05	0.000152	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	6.01e-05	0.000151	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.01e-05	0.000151	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP2B6—malignant glioma	5.99e-05	0.00015	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.95e-05	0.000149	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—BCAN—malignant glioma	5.95e-05	0.000149	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—BCAN—malignant glioma	5.9e-05	0.000148	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.89e-05	0.000148	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.86e-05	0.000147	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NCOR1—malignant glioma	5.73e-05	0.000144	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PIK3CA—malignant glioma	5.65e-05	0.000142	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PIK3CA—malignant glioma	5.65e-05	0.000142	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	5.65e-05	0.000142	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTT1—malignant glioma	5.64e-05	0.000142	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.63e-05	0.000141	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—AKT1—malignant glioma	5.51e-05	0.000138	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—AKT1—malignant glioma	5.51e-05	0.000138	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—IDH1—malignant glioma	5.48e-05	0.000138	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—ASMT—malignant glioma	5.36e-05	0.000135	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SPHK1—malignant glioma	5.3e-05	0.000133	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS1—malignant glioma	5.28e-05	0.000133	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.24e-05	0.000132	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CYP2C18—malignant glioma	5.19e-05	0.00013	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.14e-05	0.000129	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.1e-05	0.000128	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—IDH2—malignant glioma	5.09e-05	0.000128	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTP1—malignant glioma	5.07e-05	0.000127	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—BCAN—malignant glioma	5.04e-05	0.000127	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CAT—malignant glioma	4.93e-05	0.000124	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—BCHE—malignant glioma	4.91e-05	0.000123	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.9e-05	0.000123	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—COX8A—malignant glioma	4.86e-05	0.000122	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—SLC5A5—malignant glioma	4.85e-05	0.000122	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—IDH2—malignant glioma	4.79e-05	0.00012	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP2B6—malignant glioma	4.78e-05	0.00012	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—IDH2—malignant glioma	4.75e-05	0.000119	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.69e-05	0.000118	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CAV1—malignant glioma	4.67e-05	0.000117	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NCOR1—malignant glioma	4.66e-05	0.000117	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—AKT1—malignant glioma	4.62e-05	0.000116	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—AKT1—malignant glioma	4.62e-05	0.000116	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.59e-05	0.000115	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.51e-05	0.000113	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.48e-05	0.000113	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP2B6—malignant glioma	4.47e-05	0.000112	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.46e-05	0.000112	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—IDH1—malignant glioma	4.37e-05	0.00011	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.37e-05	0.00011	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PIK3CA—malignant glioma	4.36e-05	0.00011	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.34e-05	0.000109	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.3e-05	0.000108	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CG—malignant glioma	4.26e-05	0.000107	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SPHK1—malignant glioma	4.23e-05	0.000106	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTT1—malignant glioma	4.2e-05	0.000105	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP2C18—malignant glioma	4.15e-05	0.000104	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—ASMT—malignant glioma	4.14e-05	0.000104	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—IDH1—malignant glioma	4.12e-05	0.000104	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PPARG—malignant glioma	4.11e-05	0.000103	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—IDH1—malignant glioma	4.09e-05	0.000103	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—IDH2—malignant glioma	4.06e-05	0.000102	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SPHK1—malignant glioma	3.99e-05	0.0001	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	3.98e-05	0.0001	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SPHK1—malignant glioma	3.95e-05	9.93e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS1—malignant glioma	3.93e-05	9.88e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.92e-05	9.85e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.91e-05	9.81e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTP1—malignant glioma	3.91e-05	9.81e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—BCAN—malignant glioma	3.89e-05	9.77e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.87e-05	9.73e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.85e-05	9.68e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.83e-05	9.62e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2B6—malignant glioma	3.82e-05	9.59e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CAT—malignant glioma	3.8e-05	9.55e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CAV1—malignant glioma	3.8e-05	9.53e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CD—malignant glioma	3.74e-05	9.4e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—BCHE—malignant glioma	3.66e-05	9.19e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.65e-05	9.18e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.63e-05	9.11e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—SLC5A5—malignant glioma	3.61e-05	9.08e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NCOR1—malignant glioma	3.59e-05	9.02e-05	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—AKT1—malignant glioma	3.57e-05	8.95e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—IDH1—malignant glioma	3.49e-05	8.77e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CG—malignant glioma	3.46e-05	8.68e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.42e-05	8.58e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.39e-05	8.5e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SPHK1—malignant glioma	3.38e-05	8.49e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTT1—malignant glioma	3.35e-05	8.42e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PPARG—malignant glioma	3.34e-05	8.38e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.33e-05	8.36e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP2C18—malignant glioma	3.31e-05	8.31e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CB—malignant glioma	3.26e-05	8.19e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.25e-05	8.18e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—malignant glioma	3.23e-05	8.11e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.21e-05	8.07e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTT1—malignant glioma	3.16e-05	7.94e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS1—malignant glioma	3.14e-05	7.89e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—IDH2—malignant glioma	3.13e-05	7.87e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTT1—malignant glioma	3.13e-05	7.87e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.12e-05	7.84e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CD—malignant glioma	3.04e-05	7.63e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS1—malignant glioma	2.96e-05	7.44e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.95e-05	7.42e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.95e-05	7.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS1—malignant glioma	2.94e-05	7.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CAV1—malignant glioma	2.93e-05	7.35e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.93e-05	7.35e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—BCHE—malignant glioma	2.92e-05	7.34e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTP1—malignant glioma	2.91e-05	7.31e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—SLC5A5—malignant glioma	2.89e-05	7.25e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.84e-05	7.14e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CAT—malignant glioma	2.83e-05	7.11e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTEN—malignant glioma	2.82e-05	7.08e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—BCHE—malignant glioma	2.75e-05	6.92e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.74e-05	6.89e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—BCHE—malignant glioma	2.73e-05	6.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.72e-05	6.83e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.7e-05	6.77e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—IDH1—malignant glioma	2.7e-05	6.77e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTT1—malignant glioma	2.68e-05	6.72e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NCOR1—malignant glioma	2.67e-05	6.72e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CG—malignant glioma	2.67e-05	6.69e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.66e-05	6.68e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CB—malignant glioma	2.65e-05	6.65e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—malignant glioma	2.63e-05	6.59e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SPHK1—malignant glioma	2.61e-05	6.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PPARG—malignant glioma	2.57e-05	6.46e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.55e-05	6.42e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.55e-05	6.4e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.53e-05	6.35e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS1—malignant glioma	2.51e-05	6.3e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.5e-05	6.28e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CD—malignant glioma	2.34e-05	5.89e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—BCHE—malignant glioma	2.33e-05	5.86e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTP1—malignant glioma	2.32e-05	5.84e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—SLC5A5—malignant glioma	2.3e-05	5.79e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTEN—malignant glioma	2.29e-05	5.75e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CAT—malignant glioma	2.26e-05	5.68e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.2e-05	5.53e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTP1—malignant glioma	2.19e-05	5.5e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CAV1—malignant glioma	2.18e-05	5.48e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.18e-05	5.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTP1—malignant glioma	2.17e-05	5.45e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.16e-05	5.42e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NCOR1—malignant glioma	2.14e-05	5.37e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CAT—malignant glioma	2.13e-05	5.35e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CAT—malignant glioma	2.11e-05	5.31e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.08e-05	5.23e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTT1—malignant glioma	2.07e-05	5.19e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CB—malignant glioma	2.04e-05	5.13e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—malignant glioma	2.02e-05	5.08e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NCOR1—malignant glioma	2.01e-05	5.06e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NCOR1—malignant glioma	2e-05	5.01e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CA—malignant glioma	1.99e-05	4.99e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CG—malignant glioma	1.99e-05	4.99e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS1—malignant glioma	1.94e-05	4.86e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PPARG—malignant glioma	1.92e-05	4.81e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.88e-05	4.73e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTP1—malignant glioma	1.86e-05	4.66e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CAT—malignant glioma	1.81e-05	4.54e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—BCHE—malignant glioma	1.8e-05	4.52e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.78e-05	4.47e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTEN—malignant glioma	1.76e-05	4.43e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CD—malignant glioma	1.75e-05	4.39e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CAV1—malignant glioma	1.74e-05	4.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NCOR1—malignant glioma	1.71e-05	4.28e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CAV1—malignant glioma	1.64e-05	4.12e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CAV1—malignant glioma	1.63e-05	4.09e-05	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AKT1—malignant glioma	1.62e-05	4.08e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CA—malignant glioma	1.62e-05	4.06e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CG—malignant glioma	1.59e-05	3.98e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.55e-05	3.9e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PPARG—malignant glioma	1.53e-05	3.85e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CB—malignant glioma	1.52e-05	3.82e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—malignant glioma	1.51e-05	3.79e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.49e-05	3.75e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.48e-05	3.72e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PPARG—malignant glioma	1.44e-05	3.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTP1—malignant glioma	1.43e-05	3.6e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PPARG—malignant glioma	1.43e-05	3.59e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CD—malignant glioma	1.39e-05	3.5e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CAT—malignant glioma	1.39e-05	3.5e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CAV1—malignant glioma	1.39e-05	3.49e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.33e-05	3.34e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AKT1—malignant glioma	1.32e-05	3.31e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NCOR1—malignant glioma	1.32e-05	3.31e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTEN—malignant glioma	1.31e-05	3.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.31e-05	3.3e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.3e-05	3.27e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CG—malignant glioma	1.27e-05	3.18e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CA—malignant glioma	1.25e-05	3.13e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PPARG—malignant glioma	1.22e-05	3.07e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CB—malignant glioma	1.22e-05	3.05e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—malignant glioma	1.2e-05	3.02e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.15e-05	2.88e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.14e-05	2.85e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—malignant glioma	1.13e-05	2.85e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—malignant glioma	1.13e-05	2.83e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CD—malignant glioma	1.11e-05	2.8e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CAV1—malignant glioma	1.07e-05	2.69e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTEN—malignant glioma	1.05e-05	2.64e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AKT1—malignant glioma	1.02e-05	2.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTEN—malignant glioma	9.9e-06	2.49e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTEN—malignant glioma	9.81e-06	2.46e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.77e-06	2.45e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CB—malignant glioma	9.7e-06	2.44e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—malignant glioma	9.61e-06	2.41e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PPARG—malignant glioma	9.43e-06	2.37e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CA—malignant glioma	9.28e-06	2.33e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.59e-06	2.16e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTEN—malignant glioma	8.38e-06	2.11e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKT1—malignant glioma	7.58e-06	1.9e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.49e-06	1.88e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—malignant glioma	7.42e-06	1.86e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CA—malignant glioma	7.41e-06	1.86e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CA—malignant glioma	6.98e-06	1.75e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.92e-06	1.74e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTEN—malignant glioma	6.47e-06	1.63e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKT1—malignant glioma	6.05e-06	1.52e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CA—malignant glioma	5.91e-06	1.49e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKT1—malignant glioma	5.7e-06	1.43e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKT1—malignant glioma	5.65e-06	1.42e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKT1—malignant glioma	4.83e-06	1.21e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.56e-06	1.15e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKT1—malignant glioma	3.73e-06	9.37e-06	CbGpPWpGaD
